SEC investigates CSX's accounting
US railroad CSX disclosed today in a 10-Q filing lodged with the Securities and Exchange ...
R: IN LINEGXO: TRADING UPDATE TIMEMAERSK: ROARING BACKFDX: TAILWINDSFDX: WHAT TO EXPECTKO: ABOUT ALL THAT TARIFF NONSENSEKO: PROCUREMENTKO: TARIFFS AND IMPACT OUTSIDE OF THE USKO: TARIFFS AND IMPACT IN THE USKO: TRADING UPDATE HD: DIY RE-PRICINGZIM: A RISING TIDE LIFTS ALL BOATSTSLA: CHINA THREATDAC: KEY REMARKSDAC: SURGING GM: SUPPLY CHAIN WOESMAERSK: ROTTERDAM TEMPORARY SUSPENSION OF OPERATIONSATSG: OWNERSHIP UPDATE
R: IN LINEGXO: TRADING UPDATE TIMEMAERSK: ROARING BACKFDX: TAILWINDSFDX: WHAT TO EXPECTKO: ABOUT ALL THAT TARIFF NONSENSEKO: PROCUREMENTKO: TARIFFS AND IMPACT OUTSIDE OF THE USKO: TARIFFS AND IMPACT IN THE USKO: TRADING UPDATE HD: DIY RE-PRICINGZIM: A RISING TIDE LIFTS ALL BOATSTSLA: CHINA THREATDAC: KEY REMARKSDAC: SURGING GM: SUPPLY CHAIN WOESMAERSK: ROTTERDAM TEMPORARY SUSPENSION OF OPERATIONSATSG: OWNERSHIP UPDATE
SEEKING ALPHA reports:
– A coronavirus vaccine from Moderna (NASDAQ:MRNA) may shortly join a jab from Pfizer in being distributed across the country, with the FDA to decide on emergency use as early as Friday.
– As soon as it gets the green light, the federal government plans to ship just under 6M initial doses, which is more than double the 2.9M shipped by Pfizer this week.
– Distribution will also be more widespread. Medical supply company McKesson (NYSE:MCK) will obtain the doses from Moderna for packaging and distribution to 3,285 sites nationwide, five times more than…
To read the full post, please click here.
Comment on this article